BC
MRNA icon

Brookfield Corp’s Moderna MRNA Stock Holding History

Brookfield Corp’s Portfolio MRNA Stock Details MRNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-40,368
Closed -$6.2M – 700
2023
Q1 		$6.2M Buy
40,368
+12,521
+45% +$2.07M 0.02% 254
2022
Q4 		$5M Buy
27,847
+17,371
+166% +$2.84M 0.02% 268
2022
Q3 		$1.24M Buy
+10,476
New +$1.59M ﹤0.01% 513
2022
Q1 		– Sell
-7,217
Closed -$1.83M – 729
2021
Q4 		$1.83M Buy
7,217
+4,630
+179% +$1.35M 0.01% 345
2021
Q3 		$996K Sell
2,587
-912
-26% -$336K ﹤0.01% 420
2021
Q2 		$822K Buy
+3,499
New +$625K ﹤0.01% 486

Other funds holding MRNA

Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
FP
Flagship Pioneering Cambridge, Massachusetts $1.54B AUM 86.39% 1-Year Est. Return
Coatue Management
Coatue Management New York $48.6B AUM 94.27% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
TP
Theleme Partners London, United Kingdom $1.68B AUM 19.9% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Brookfield Corp's MRNA Position: Q2 2023 in Review

Brookfield Corp sold out of Moderna (MRNA) in Q2 2023, closing a stake of 40,368 shares — an estimated $6.2M sold.

Brookfield Corp first reported a position in MRNA in Q2 2021 and held it in 6 quarters. The position peaked at $6.2M in Q1 2023. 965 funds tracked by Wall St. Rank hold MRNA as of Q2 2023.

  • Brookfield Corp reported no remaining Moderna position as of Q2 2023 after selling out during the quarter.
  • Brookfield Corp sold 40,368 Moderna shares in Q2 2023, an estimated $6.2M.
  • Brookfield Corp first reported a position in Moderna in Q2 2021 and held it in 6 quarters.
  • Brookfield Corp's Moderna position peaked at $6.2M in Q1 2023.
  • 965 funds tracked by Wall St. Rank held Moderna as of Q2 2023.

Based on Brookfield Corp's 13F filing for Q2 2023, filed 14 Aug 2023.